Immunovant Inc
IMVT
Market Cap$2.68B
Close$
$4.60
67.8% downside
Current Fair Value
67.8% downsideOvervalued by 67.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.68 Billion |
|---|---|
| Enterprise Value | $2.31 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.88 |
| Beta | 0.81 |
| Outstanding Shares | 146,922,338 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.07 |
|---|---|
| PEG | -7.05 |
| Price to Sales | - |
| Price to Book Ratio | 7.15 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -6.88 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data